Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Subjective Cognitive Decline Between the German and Chinese and Early Diagnosis of Alzheimer's Disease Based on Radiogenomics

NCT04696315 is registered in ClinicalTrials.gov with Ying Han as lead sponsor.

NCT NCT04696315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04696315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Subjective Cognitive Decline Between the German and Chinese and Early Diagnosis of Alzheimer's Disease Based on Radiogenomics
Lead sponsor
Ying Han
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2025
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, gene, neuroimaging, subjective cognitive decline